8:00 - 8:30
Welcome address
Moderators: Christian Manegold (Mannheim, Germany), Jacek Niklinski (Bialystok, Poland), Saulius Cicenas (Vilnius, Lithuania)
Zivile Gudleviciene - Advicer to the Prime Minister on Healthcare and People with Disabilities
Dalius Jatuzis - Dean of the Faculty of Medicine Vilnius University
Neringa Ciakiene - Director of Lithuanian Cancer Patients Coalition „POLA“
Marius Kincius - Deputy Director of National Cancer Institute
08:35 - 9:30
Lung Cancer Diagnostics
Chairs: Kestutis Suziedelis (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland)
08:35 - 08:50
Current diagnostic criteria for mesothelioma diagnosis
Mauro Papotti (Torino, Italy) online
08:50 - 09:05
Pseudoprogression and Hyperprogression During Immune Checkpoint Inhibitor Therapy for Solid Tumors
Rossitza Krasteva (Sofia, Bulgaria) onsite
09:05 - 9:20
Advances in Lung Cancer Imagining
Donatas Vajauskas (Kaunas, Lithuania) onsite
9:55-10:40
Surgery for Lung Cancer
Chairs: Saulius Cicenas (Vilnius, Lithuania), Miroslaw Kozlowski (Bialystok, Poland)
9:55-10:10
Treatment of lung metastases in thoracic oncology
Miroslaw Kozlowski (Bialystok, Poland) onsite
10:10-10:25
Surgical treatment of multiple primary lung cancer: every lesions matter
Sigitas Zaremba (Vilnius, Lithuania) onsite
10:45-11:20
Satellite Roche
Chairs: Kestutis Suziedelis (Vilnius, Lithuania)
10:45-11:20
Immune therapy for 1L treatment in advanced NSCLC
Alvydas Cesas (Klaipeda, Lithuania) onsite
11:45-12:20
Satellite BMS
Chairs: Alvydas Cesas (Klaipeda, Lietuva)
11:45-12:20
Added value of dual immunotherapy and chemotherapy in first line treatment of NSCLC
Lina Puzauskiene (Kaunas, Lithuania) onsite
12:25-13:25
Satellite MSD
Chairs: Saulius Cicenas (Vilnius, Lietuva)
12:25-13:25
Treatment decisions for first line metastatic NSCLC: Balancing monotherapy vs combination
Marius Zemaitis (Kaunas, Lithuania) onsite
14:35-15:30
Multimodality Lung cancer Treatment
Session 1
Chairs: Rita Steponaviciene (Vilnius, Lithuania), Mikk Saretok (Talinn, Estonia)
14:35-14:50
NSCLC: newer aspects on preoperative medical therapy.
Christian Manegold (Manheim, Germany) onsite
14:50-15:05
Immune checkpoint inhibitors as adjuvant therapy in patients with resected NSCLC
Robert Pirker (Vienna Austria) online
15:05-15:20
Radical Radiotherapy in NSCLC in Baltic States/Estonia
Mikk Saretok (Talinn, Estonia) onsite
15:30-16:05
Satellite Pfizer
15:30-16:05
Modern treatment modalities of ALK mutated non-small cell lung cancer
Neringa Vaguliene (Kaunas, Lithuania) onsite
16:25-17:25
Satellite AstraZeneca
16:25-17:25
Treatment of extensive stage small cell lung cancer. What is the role of durvalumab?
Bjorn Henning Gronberg (Trondheim, Norway) onsite
17:30 - 18:25
Multimodality Lung cancer Treatment
Session 2
Chairs: Rita Steponaviciene (Vilnius, Lithuania), Mikk Saretok (Talinn, Estonia)
17:30-17:45
Modern Management of SCLC
Sofia Baka (Athens, Greece) online
17:45-18:00
Current clinical study concepts in lung cancer
Lothar Richard Pilz (Manheim, Germany) onsite
18:00-18:15
The combination of radiotherapy andhemotherapy in the management of SCLC Treatment in China
Yi Pan (Guanghzou, China)
18:30 - 18:45
Closing Remarks
Moderation: Saulius Cicenas (Vilnius, Lithuania), Jacek Niklinski (Bialystok, Poland), Christian Manegold (Manheim, Germany)